CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 55 filers reported holding CTI BIOPHARMA CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $22,000 | +37.5% | 52,768 | +25.1% | 0.00% | – |
| Q3 2016 | $16,000 | -40.7% | 42,164 | -47.3% | 0.00% | – |
| Q2 2016 | $27,000 | -99.2% | 80,061 | -98.7% | 0.00% | -100.0% |
| Q1 2016 | $3,212,000 | -54.7% | 6,043,618 | +4.8% | 0.00% | -50.0% |
| Q4 2015 | $7,092,000 | +13.2% | 5,766,088 | +34.4% | 0.00% | 0.0% |
| Q3 2015 | $6,264,000 | -24.2% | 4,290,232 | +1.2% | 0.00% | 0.0% |
| Q2 2015 | $8,268,000 | +8.8% | 4,239,943 | +1.0% | 0.00% | 0.0% |
| Q1 2015 | $7,598,000 | -22.7% | 4,197,699 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $9,827,000 | +24.8% | 4,163,937 | +28.0% | 0.00% | 0.0% |
| Q3 2014 | $7,872,000 | -16.5% | 3,252,712 | -3.1% | 0.00% | -33.3% |
| Q2 2014 | $9,429,000 | – | 3,355,586 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 44,796,940 | $18,053,000 | 3.63% |
| Stonepine Capital Management, LLC | 2,617,136 | $1,067,000 | 0.64% |
| FIRST NEW YORK SECURITIES LLC /NY | 35,000 | $14,266,000 | 0.03% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 526,210 | $2,157,000 | 0.02% |
| Caprock Group, LLC | 150,000 | $61,000 | 0.02% |
| TIEDEMANN ADVISORS, LLC | 334,310 | $136,000 | 0.01% |
| JW Asset Management, LLC | 50,254 | $21,000 | 0.01% |
| Nine Chapters Capital Management LLC | 17,200 | $7,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 60,419 | $24,000 | 0.01% |
| WASHINGTON TRUST Co | 314,000 | $128,000 | 0.01% |